Tuesday, October 1, 2013

• Pfizer Invites Public To View And Listen To Webcast Of October 29 Conference Call With AnalystsBusiness Wire( (Tue, Oct 1)

Monday, September 30, 2013

• Shantanu Narayen Elected To Pfizer's Board Of DirectorsBusiness Wire( (Mon, Sep 30)
• Advil® Becomes Official Pain Reliever of the National Hockey League and the 30 Team Athletic TrainersBusiness Wire( (Mon, Sep 30)

Tuesday, September 24, 2013

• Pfizer Announces Data For XELJANZ® (tofacitinib citrate) In Rheumatoid Arthritis To Be Presented At The American College Of Rheumatology 2013 Annual MeetingBusiness Wire( (Tue, Sep 24)

Thursday, September 12, 2013

• ViiV Healthcare Presents Positive Data from Phase IIIb/IV Study of Dolutegravir vs Darunavir in Treatment-Naive Adults with HIV-1PR Newswire( (Thu, Sep 12)

Wednesday, September 4, 2013

• ViiV Healthcare Expands HIV/AIDS Community Support in Hard-Hit Southern U.S.PR Newswire( (Wed, Sep 4)

Tuesday, September 3, 2013

• Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare ConferenceBusiness Wire( (Tue, Sep 3)
• Subanalysis of Phase III ARISTOTLE Trial of Eliquis® (apixaban) Demonstrated Consistent Results Versus Warfarin in Patients with Nonvalvular Atrial Fibrillation with or without Valvular Heart DiseaseBusiness Wire( (Tue, Sep 3)

Saturday, August 31, 2013

• New Eliquis® (apixaban) Post-hoc Subanalysis of the Phase III ARISTOTLE trial Demonstrated that within 30 Days of a Procedure, Stroke or Systemic Embolism and Major Bleeding were UncommonBusiness Wire( (Sat, Aug 31)

Thursday, August 29, 2013

• Pfizer Completes Pneumococcal Pneumonia Case Accrual For CAPiTA, Adult Vaccine Clinical Trial of Prevenar 13*Business Wire( (Thu, Aug 29)

Monday, August 26, 2013

• Introducing New Advil® Film Coated Tablets – Designed to Stop Pain Before It Gets WorseBusiness Wire( (Mon, Aug 26)

Monday, August 12, 2013

• UPDATE: Multimedia Assets Now Available: ViiV Healthcare announces U.S. approval of Tivicay® (dolutegravir) for the treatment of HIV-1PR Newswire( (Mon, Aug 12)